Vancomycin Hydrochloride Injection, Powder, For Solution
Product Images NDC 83634-114

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vancomycin Hydrochloride (NDC 83634-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Van0x 0000 01)

Chemical structure diagram of vancomycin hydrochloride showing the molecular arrangement of atoms, including rings, hydroxyl groups, amines, and chlorine atoms, with an HCl molecule indicated.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Van0x 0000 02)

Vancomycin Hydrochloride 750 mg injection powder vial label for intravenous and oral use. The label states the medication is preservative-free, sterile, and contains vancomycin equivalent to 750 mg per vial. It includes preparation and storage instructions, prescribing information directions, and is manufactured by Avenacy, LLC in Schaumburg, Illinois, USA.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Van0x 0000 03)

Vancomycin Hydrochloride for Injection label showing a dosage strength of 1.25 grams per vial. The label indicates it is sterile, preservative-free powder for injection, intended for intravenous and oral use after proper reconstitution and dilution. It is packaged by Avenacy, LLC, with directions to see prescribing information for use and dosage details. The label also includes storage instructions and barcode information.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Van0x 0000 04)

Vancomycin Hydrochloride for Injection label showing 1.5 grams per vial strength. The label indicates it is preservative-free, for oral use with prescribing information, and requires further dilution for intravenous use after reconstitution. It includes directions for preparation, storage conditions, and discarding unused portions, with the labeler listed as Avenacy, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.